Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Dihydroxyphenylalanine MeSH Descriptor Data 2025


MeSH Heading
Dihydroxyphenylalanine
Tree Number(s)
D02.092.311.200
D02.455.426.559.389.657.166.175.200
D12.125.072.050.685.400
D12.125.072.050.875.130
Unique ID
D004295
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004295
Annotation
check text to see if LEVODOPA; (L-DOPA); is not meant instead
Scope Note
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
Entry Term(s)
3,4-Dihydroxyphenylalanine
3-Hydroxy-DL-tyrosine
Dihydroxyphenylalanine Hydrochloride, (2:1)
Dopa
beta-Hydroxytyrosine
Pharm Action
Dopamine Agents
Registry Numbers
63-84-3
37466-26-5
Related Numbers
37466-26-5
CAS Type 1 Name
DL-Tyrosine, 3-hydroxy-
NLM Classification #
WK 725
See Also
Dopa Decarboxylase
Dopamine
Public MeSH Note
2002; see DOPA 1966-2001
History Note
2002(1966); for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE (NM) 1989-1991
Date Established
2002/01/01
Date of Entry
1999/01/01
Revision Date
2018/06/30
Dihydroxyphenylalanine Preferred
Dihydroxyphenylalanine Hydrochloride, (2:1) Narrower
page delivered in 0.164s